What did @ohmysebb actually say?
The claim is simple and sweeping: stop taking all peptides because the long-term effects are "super scary." The creator also implies peptides help users get leaner and more attractive, which they frame as part of the problem. That's the whole argument. No studies cited, no mechanism explained, no distinction between peptide types.
To be fair, the concern about long-term safety data isn't entirely baseless. But "stop taking them" delivered without any clinical context to 300,000 viewers is a different thing from a responsible warning. Vague fear is not the same as evidence. When someone makes a sweeping health claim to hundreds of thousands of people, the least we can do is check whether the claim holds up.
Does the science back up the 'scary long-term effects' claim?
Partially, but not in the way the video implies. The honest answer is that long-term human data on most research peptides is genuinely limited, and that gap is a real concern. But "limited data" is not the same as "proven dangerous."
BPC-157, one of the most studied peptides in this category, has an extensive animal literature showing tissue repair and gastroprotective effects with low observed toxicity (Sikiric et al., 2018, Current Pharmaceutical Design). Human clinical trials remain sparse. TB-500 (a synthetic fragment of thymosin beta-4) similarly lacks robust long-term human RCTs. GHK-Cu has decades of cosmetic and wound-healing research behind it with no serious safety signals in topical or low-dose contexts (Pickart & Margolina, 2018, Biomolecules). MK-677, an oral ghrelin mimetic sometimes grouped with peptides, does carry legitimate concern around insulin resistance and cortisol elevation with chronic use (Svensson et al., 1998, Journal of Clinical Endocrinology and Metabolism). Semax and selank have a longer history of clinical use in Eastern European research settings, with reasonable short-term tolerability data. The "scary" framing without distinguishing between any of these is not scientifically useful.
What did they get wrong, and what did they accidentally get right?
Wrong: treating every peptide as one monolithic category with identical risk profiles. BPC-157 and MK-677 are not the same compound, carry different mechanisms, and have different evidence bases. Lumping them together is the kind of shortcut that sounds edgy on TikTok but misleads people who might actually benefit from informed decision-making.
Also wrong: the implication that cosmetic or body composition effects are themselves a red flag. The fact that a compound may support recovery or body composition is not evidence of harm. That logic would apply to creatine.
What they accidentally got right: long-term human safety data for most injectable research peptides is genuinely thin. Most peptides in the optimization space are not FDA-approved for the uses being promoted online. That regulatory gap is real, and patients deserve to know it. Compounded peptide formulations vary in purity and sterility, which adds a sourcing risk the video doesn't actually mention, but the general concern about unregulated use has some merit.
What should you actually know before making a decision?
The absence of long-term safety data is a legitimate reason for caution, not a reason to panic. Peptides vary enormously in their mechanisms, research depth, and risk profiles. Anyone using or considering peptides should be doing so under clinical supervision, with sourcing from regulated compounding pharmacies, and with realistic expectations about what the evidence does and does not support.
A few specific points worth knowing: injectable peptides carry inherent risks related to sterility and injection technique that oral or topical compounds do not. Growth hormone secretagogues like CJC-1295 and ipamorelin stimulate endogenous GH release, and while short-term studies show tolerability (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism), nobody has run a 10-year cardiovascular outcomes trial. That is the honest version of the "we don't fully know" concern. For peptides like GHK-Cu with decades of topical use and no serious adverse event literature, the risk calculus looks different. Context matters. A TikTok that ignores context is not health information. It's noise.